Cargando…
Clinical implications of lncRNA LINC-PINT in cancer
Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat many disorders, including cancers. Several RNA-based therapeutics (ASOs and small interfering RNAs) have gained FDA approval over the past decade. And with their potent effects, lncRNA-based therapeutics are of em...
Autores principales: | Bukhari, Ihtisham, Khan, Muhammad Riaz, Li, Fazhan, Swiatczak, Bartlomiej, Thorne, Rick Francis, Zheng, Pengyuan, Mi, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064087/ https://www.ncbi.nlm.nih.gov/pubmed/37006616 http://dx.doi.org/10.3389/fmolb.2023.1097694 |
Ejemplares similares
-
lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR
por: Huang, Qing, et al.
Publicado: (2019) -
LncRNA LINC00944 Promotes Tumorigenesis but Suppresses Akt Phosphorylation in Renal Cell Carcinoma
por: Chen, Chiheng, et al.
Publicado: (2021) -
CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo
por: Li, Chunjing, et al.
Publicado: (2021) -
LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint
por: Hong, Lei, et al.
Publicado: (2019) -
A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra
por: Simchovitz, Alon, et al.
Publicado: (2020)